在类风湿性关节炎中间歇性肺部疾病:一篇评论
Shahad Al-Baldawi1, Gabriel Zúñiga Salazar2, Diego Zúñiga2
1Department of Rheumatology, Al-Yarmouk Teaching Hospital, Baghdad, IRQ.
Cureus
|March 7, 2024
概括
类风湿性关节炎相关的间歇性肺病 (RA-ILD) 影响类风湿性关节炎 (RA) 患者,导致严重的健康问题. 本综述涵盖了RA-ILD的流行,发病,诊断和治疗选择.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,主要影响关节,但可以表现在关节外区域.
- 类风湿性关节炎相关的间歇性肺病 (RA-ILD) 是 RA 的严重并发症,导致显著的发病率和死亡率.
- 在RA患者中管理肺部表现为医疗保健提供者带来了挑战.
研究的目的:
- 为了提供与类风湿性关节炎相关的间歇性肺病 (RA-ILD) 的概述.
- 讨论RA-ILD的患病率,致病性,诊断挑战和查方式.
- 审查RA-ILD的药理管理策略.
主要方法:
- 关于类风湿性关节炎和相关间歇性肺部疾病的文献综述.
- 对目前对RA-ILD病原体的理解进行分析.
- 对RA-ILD的诊断和查方法的评估.
- 对药理疗法的审查,包括葡萄糖皮质类药物,DMARDs,免疫抑制剂和生物药物.
主要成果:
- RA-ILD是RA的一个显著的关节外表现,患病率各不相同.
- 不断发展的概念将RA-ILD病原体与RA的自身免疫级联联系起来.
- 早期识别和有效管理对于改善RA-ILD患者的治疗结果至关重要.
- 为了管理RA-ILD,正在探索多种药理学药物.
结论:
- 风湿性关节炎 (RA-ILD) 是风湿性关节炎的一个关键性肺部并发症,需要全面的理解和管理.
- 在了解病原,诊断和治疗方面取得的进展为RA-ILD提供了改进的策略.
- 多学科方法对于优化患者护理和RA-ILD的结果至关重要.
相关概念视频
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K